medicare coverage of glp 1 CMS Issues Guidance on GLP-1 Anti-Obesity Drugs Medicare GLP-1 Drug Coverage -
Description
New England Journal of Medicine, 384(11), 989-1002

Retrieved 30 March 2023

The influence of major players is significant, as they set trends that smaller companies often follow, thereby shaping the overall market dynamics

Localized reactions have been reported in patients using liraglutide and dulaglutide [43,44,45,46], while generalized urticaria and systemic anaphylaxis have been associated with exenatide and tirzepatide [47,48,49,50,51]

Researchers at Loyola University Chicagos Parkinson School of Health Sciences and Public Health have uncovered promising findings that GLP-1 medications like Ozempic, often prescribed for diabetes and weight loss, may also reduce the risks associated with opioid and alcohol use disorders

The technical term is it's a GLP-1 receptor agonist, and just like GLP-1, it increases insulin release, it lowers blood sugar, the stomach empties slower, but it was different from GLP-1 in one really important way
